Kit with enteral dietary composition consisting of Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum
Abstract
Enteral compositions containing Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum, each at a concentration equal to or greater than 1×10 11 CFU per gram, are useful as adjuncts for enteral formulations and as oral nutritional supplements. The compositions can be administered before, during or at the end of an enteral formulation administration. The compositions can be administered separately or mixed with the enteral formulation. The compositions can also be employed at the end of the daily administration in order to prevent the colonization of the enteral tube by the other pathogens. The compositions can also be used as supplement to any liquid, creamy or pasty foodstuff. The present invention relates to a kit comprising two containers, one containing a foodstuff and the other containing the enteral composition consisting of Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum.
Claims
exact text as granted — not AI-modified1. A kit comprising:
a container A holding a composition, said composition comprising a mixture of live lactic acid bacteria consisting of Streptococcus thermophilus, Bifidobacterium longum and Bifidobacterium infantis, wherein the Streptococcus thermophilus concentration is at least 1×10 11 CFU per gram, the Bifidobacterium longum concentration is at least 1×10 11 CFU per gram, and the Bifidobacterium infantis concentration is at least 1×10 10 CFU per gram, each concentration based on the total composition, and
a container B holding a liquid, creamy or pasty foodstuff, both said containers A and B being closed and openable at the moment of consuming said foodstuff, and said container A being arranged for the purpose of supplementing the composition held therein to the foodstuff held in container B, at the moment of consuming said foodstuff.
2. The kit of claim 1 , wherein the Streptococcus thermophilus concentration is 1×10 11 to 1×10 14 CFU per gram, the Bifidobacterium longum concentration is 1×10 11 to 1×10 14 CFU per gram, and the Bifidobacterium infantis concentration is 1×10 10 to 1×10 13 CFU per gram, each concentration based on the total composition.
3. The kit of claim 1 , wherein the composition is in a liquid form.
4. The kit of claim 1 , wherein the composition is in a dry powder form.
5. The kit of claim 1 , wherein the composition is an enteral dietary composition.
6. The kit of claim 2 , wherein the composition is an enteral dietary composition.
7. The kit of claim 3 , wherein the composition is an enteral dietary composition.
8. The kit of claim 4 , wherein the composition is an enteral dietary composition.Join the waitlist — get patent alerts
Track USRE39876E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.